Collectively, these data support a clear cell autonomous role for MBOAT7-driven acylation of LPI lipids as a key protective mechanism against obesity-linked NAFLD progression, hyperinsulinemia, and systemic insulin resistance. Here, MBOAT7 is linked to metabolic dysfunction-associated steatotic liver disease.